A prospective interventional study on the effects of Yoga on metabolic dysfunction-associated steatotic liver disease

A prospective interventional study on the effects of Yoga on metabolic dysfunction-associated steatotic liver disease - A prospective interventional study on the effects of Yoga on metabolic dysfunction-associated steatotic liver disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000057806

Enrollment

Registered

2025-05-10

Start date

2025-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic dysfunction associated steatotic liver disease

Interventions

Participants will be required to complete a 12-week yoga program consisting of at least three 45-minute yoga sessions per week. This includes a monthly in-person yoga workshop and a weekly online sess

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with MASLD at the Department of Gastroenterology, Tohoku University Hospital, and receiving follow-up care with lifestyle guidance in an outpatient setting. (2) Individuals aged 18 years or older, but under 75 years. (3) No restriction on gender. (4) Liver biopsy status is not a criterion. (5) Patients classified as Child-Pugh Class A or B.

Exclusion criteria

Exclusion criteria: (1) Patients undergoing treatment for cardiovascular or respiratory diseases, with impaired cardiopulmonary function. (2) Patients undergoing treatment for muscular or neurological disorders, or those experiencing organic or functional limitations in movement. (3) Elderly individuals aged 75 and above. (4) Patients with cognitive dysfunction or psychiatric disorders. (5) Patients who are pregnant or within 28 days postpartum. (6) Patients classified as Child-Pugh Class C. (7) Patients with a pre-existing habit of physical activity such as yoga.

Design outcomes

Primary

Measure	Time frame
Liver function data (e.g. AST, ALT, G-GTP) and metabolic function data (e.g. TG, T-chol, LDL-chol, HbA1c) at 12 weeks after starting yoga.	—

Countries

Japan

Contacts

Public ContactMio Tsuruoka

Tohoku University Hospital Department of Gastroenterology

ytrsb237@gmail.com022-717-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026